PRODUCT FOCUS
VOLTAROL® TO LAUNCH NEW TOPICAL INNOVATION: NEW VOLTAROL® 140MG MEDICATED PLASTER Voltarol®, introduces a topical innovation into the pain category - the launch of new Voltarol® 140mg Medicated Plaster. Voltarol® 140mg Medicated Plaster is the only medicated pain relief plaster with anti-infl ammatory action exclusively available from behind the pharmacy counter.
The Voltarol® 140mg Medicated Plaster provides a three-way combination of effi cacy, anti-infl ammatory action and comfort :
• • •
Effi cacy –provides up to 2x as powerful pain relief vs non-medicated placebo patch², and it provides 12 hours continuous relief of the active ingredient to the site of pain.
Anti-infl ammatory action –Voltarol® 140mg contains an anti-infl ammatory. It strikes pain and infl ammation directly at its source.
Comfort – the plaster format is thin, fl exible and odourless The plaster does not contain any heating properties, which may be suitable for customers who want to use the plaster overnight.
When should it be recommended? Muscle pain fl are-ups which includes shoulder, neck, leg and arm pain. For more information about the Voltarol® range of products, go to
www.voltarol.co.uk
ARE YOU READY FOR THE HEAD LICE SEASON? INTRODUCING THE NITVIEW LEDCOMB
Nitview® Ledcomb is an internationally patented medical device that incorporates an ultraviolet light (400-405nm, light range naturally visible to the human eye) and detachable comb with micro-channelled teeth for the effective removal of both lice and nits.
The lice, their eggs and nits (the empty egg cases) glow under the UV light making them very easy to fi nd amongst the hairs and then remove with the comb.
AMCo
AMCo has launched Pevanti® – a new branded range of prednisolone tablets for the treatment of a wide range of infl ammatory and auto-immune conditions.
The range includes two new strengths of prednisolone that have not previously been available in the UK – a 10mg and 20mg.
The introduction of these two new strengths of Pevanti will allow patients to be able to take a fewer number of tablets to achieve the same daily dose if they so choose.
NEW BONJELA INVISIBLE COLD SORE CREAM Launch Supported by Major TV Campaign to Reach 17m Consumers
New bonjela Invisible Cold Sore Cream is a signifi cant innovation from RB and offers an ‘invisible’ way to not only treat but also prevent cold sores.
38% of consumers want immediate reduction in visibility of a cold sore, and unlike other creams available in the market that dry white & crusty and draw attention to the lips, bonjela Cold Sore Cream turns invisible upon application. New bonjela Invisible Cold Sore Cream is a fast acting treatment which can be applied at the fi rst signs of cold sore or can be used to help prevent an outbreak by creating a protective fi lm layer to stop environmental stimuli such as UV rays. It also prevents the attachment of virus particles to new cells minimising the risk of multiple cold sores developing.
New bonjela Invisible Cold Sore Cream is suitable from 6 years old. MRRP £5.99
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48